Randomized Phase II Trial of Anastrozole Plus Metronomic Tegafur-uracil as Neo-adjuvant Therapy in Postmenopausal Breast Cancer (Neo-ACET BC)

This study has suspended participant recruitment.
(Due to an adverse event revelation.)
Sponsor:
Collaborator:
Osaka University Hospital
Information provided by:
Translational Research Informatics Center, Kobe, Hyogo, Japan
ClinicalTrials.gov Identifier:
NCT01262274
First received: December 15, 2010
Last updated: August 15, 2012
Last verified: August 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: July 2013
  Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)